Shoreline Biosciences, Inc. Email Format
Biotechnology ResearchCalifornia, United States51-200 Employees
Shoreline's proprietary cell therapy technology platform is based on deep expertise in iPSC differentiation methods and genetic programming of the IL-15/CISH pathway for enhanced metabolic fitness and persistence of the engineered NK Cells to improve anti-cancer activity.